Crk and Abi1: Binary Molecular Switches That Regulate Abl Tyrosine Kinase and Signaling to the Cytoskeleton

Genes and Cancer

Volumn 3, Issue 5-6, 2012, Pages 402-413

  Hossain, Sajjad ^a,d   Dubielecka, Patrycja M ^a,e   Sikorski, Aleksander F ^b   Birge, Raymond B ^c   Kotula, Leszek ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b UNIVERSITY OF WROC AW   (Poland)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d STONY BROOK UNIVERSITY   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Abi1; Abl kinase; Crk; cytoskeleton; WAVE complex

Indexed keywords

ABELSON KINASE; ABL RELATED GENE KINASE; ADAPTOR PROTEIN; ANTINEOPLASTIC AGENT; BETA CATENIN; CRK LIKE PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GNF 5; IMATINIB; JANUS KINASE 3; NILOTINIB; PHOSPHOLIPASE C GAMMA; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN ABI1; PROTEIN ABI2; PROTEIN ABI3; PROTEIN CRK; PROTEIN KINASE B; PROTEIN KINASE LCK; PROTEIN KINASE ZAP 70; PROTEIN SH2; PROTEIN SH3; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; UVOMORULIN;

ACTIN FILAMENT; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BREAST CANCER; CARCINOGENESIS; CHRONIC MYELOID LEUKEMIA; COLON CANCER; COLORECTAL CANCER; CYTOSKELETON; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; ENZYME STRUCTURE; GENE MUTATION; GLIOBLASTOMA; HUMAN; LIVER CANCER; LUNG CANCER; LUNG NON SMALL CELL CANCER; MELANOMA; MOUTH CANCER; MURINE LEUKEMIA VIRUS; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STOMACH CANCER; TRANSACTIVATION; TUMOR GROWTH;

MURINE LEUKEMIA VIRUS;

EID: 84875549237     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601912460051     Document Type: Article

References (108)

1. Miller ML,Jensen LJ,Diella F, et al.Linear motif atlas for phosphorylation-dependent signaling.Sci Signal. 2008;1:ra2.
2. Pawson T,Scott JD.Signaling through scaffold, anchoring, and adaptor proteins.Science. 1997;278:2075-80.
3. Scott JD,Pawson T.Cell signaling in space and time: where proteins come together and when they're apart.Science. 2009;326:1220-4.
4. Machida K,Mayer BJ,Nollau P.Profiling the global tyrosine phosphorylation state.Mol Cell Proteomics. 2003;2:215-33.
5. Machida K,Thompson CM,Dierck K, et al.High-throughput phosphotyrosine profiling using SH2 domains.Mol Cell. 2007;26:899-915.
6. Obenauer JC,Yaffe MB.Computational prediction of protein-protein interactions.Methods Mol Biol. 2004;261:445-68.
7. Yaffe MB,Cantley LC.Signal transduction: grabbing phosphoproteins.Nature. 1999;402:30-1.
8. Schwartzberg PL,Stall AM,Hardin JD, et al.Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations.Cell. 1991;65:1165-75.
9. Tybulewicz VL,Crawford CE,Jackson PK,Bronson RT,Mulligan RC.Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene.Cell. 1991;65:1153-63.
10. Koleske AJ,Gifford AM,Scott ML, et al.Essential roles for the Abl and Arg tyrosine kinases in neurulation.Neuron. 1998;21:1259-72.
11. Gu JJ,Ryu JR,Pendergast AM.Abl tyrosine kinases in T-cell signaling.Immunol Rev. 2009;228:170-83.
12. Gu JJ,Zhang N,He YW,Koleske AJ,Pendergast AM.Defective T cell development and function in the absence of Abelson kinases.J Immunol. 2007;179:7334-43.
13. Tammer I,Brandt S,Hartig R,Konig W,Backert S.Activation of Abl by Helicobacter pylori: a novel kinase for CagA and crucial mediator of host cell scattering.Gastroenterology. 2007;132:1309-19.
14. Tegtmeyer N,Backert S.Role of Abl and Src family kinases in actin-cytoskeletal rearrangements induced by the Helicobacter pylori CagA protein.Eur J Cell Biol. 2011;90:880-90.
15. Burton EA,Plattner R,Pendergast AM.Abl tyrosine kinases are required for infection by Shigella flexneri.EMBO J. 2003;22:5471-9.
16. Nhieu GT,Enninga J,Sansonetti P,Grompone G.Tyrosine kinase signaling and type III effectors orchestrating Shigella invasion.Curr Opin Microbiol. 2005;8:16-20.
17. Abelson HT,Rabstein LS.Lymphosarcoma: virus-induced thymic-independent disease in mice.Cancer Res. 1970;30:2213-22.
18. Scott ML,Van Etten RA,Daley GQ,Baltimore D.v-abl causes hematopoietic disease distinct from that caused by bcr-abl.Proc Natl Acad Sci U S A. 1991;88:6506-10.
19. Druker BJ,Sawyers CL,Kantarjian H, et al.Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.N Engl J Med. 2001;344:1038-42.
20. Ganguly SS,Fiore LS,Sims JT, et al.c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression.Oncogene. 2012;31:1804-16.
21. Lin J,Arlinghaus R.Activated c-Abl tyrosine kinase in malignant solid tumors.Oncogene. 2008;27:4385-91.
22. Rikova K,Guo A,Zeng Q, et al.Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.Cell. 2007;131:1190-203.
23. Chen WS,Kung HJ,Yang WK,Lin W.Comparative tyrosine-kinase profiles in colorectal cancers: enhanced arg expression in carcinoma as compared with adenoma and normal mucosa.Int J Cancer. 1999;83:579-84.
24. Srinivasan D,Plattner R.Activation of Abl tyrosine kinases promotes invasion of aggressive breast cancer cells.Cancer Res. 2006;66:5648-55.
25. Srinivasan D,Sims JT,Plattner R.Aggressive breast cancer cells are dependent on activated Abl kinases for proliferation, anchorage-independent growth and survival.Oncogene. 2008;27:1095-105.
26. Gil-Henn H,Patsialou A,Wang Y,Warren MS,Condeelis JS,Koleske AJ.Arg/Abl2 promotes invasion and attenuates proliferation of breast cancer in vivo.Oncogene. 2012;:9.
27. Plattner R,Kadlec L,DeMali KA,Kazlauskas A,Pendergast AM.c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF.Genes Dev. 1999;13:2400-11.
28. Plattner R,Koleske AJ,Kazlauskas A,Pendergast AM.Bidirectional signaling links the Abelson kinases to the platelet-derived growth factor receptor.Mol Cell Biol. 2004;24:2573-83.
29. Srinivasan D,Kaetzel DM,Plattner R.Reciprocal regulation of Abl and receptor tyrosine kinases.Cell Signal. 2009;21:1143-50.
30. Furstoss O,Dorey K,Simon V,Barila D,Superti-Furga G,Roche S.c-Abl is an effector of Src for growth factor-induced c-myc expression and DNA synthesis.EMBO J. 2002;21:514-24.
31. Plattner R,Irvin BJ,Guo S, et al.A new link between the c-Abl tyrosine kinase and phosphoinositide signalling through PLC-gamma1.Nat Cell Biol. 2003;5:309-19.
32. Van Etten RA.c-Abl regulation: a tail of two lipids.Curr Biol. 2003;13:R608-10.
33. Campa F,Machuy N,Klein A,Rudel T.A new interaction between Abi-1 and betaPIX involved in PDGF-activated actin cytoskeleton reorganisation.Cell Res. 2006;16:759-70.
34. Michael M,Vehlow A,Navarro C,Krause M.c-Abl, Lamellipodin, and Ena/VASP proteins cooperate in dorsal ruffling of fibroblasts and axonal morphogenesis.Curr Biol. 2010;20:783-91.
35. Neumeister EN,Zhu Y,Richard S,Terhorst C,Chan AC,Shaw AS.Binding of ZAP-70 to phosphorylated T-cell receptor zeta and eta enhances its autophosphorylation and generates specific binding sites for SH2 domain-containing proteins.Mol Cell Biol. 1995;15:3171-8.
36. Zipfel PA,Zhang W,Quiroz M,Pendergast AM.Requirement for Abl kinases in T cell receptor signaling.Curr Biol. 2004;14:1222-31.
37. Courtneidge SA.Cancer: escape from inhibition.Nature. 2003;422:827-8.
38. Wang JY.Controlling Abl: auto-inhibition and co-inhibition?.Nat Cell Biol. 2004;6:3-7.
39. Williams JC,Weijland A,Gonfloni S, et al.The 2.35 A crystal structure of the inactivated form of chicken Src: a dynamic molecule with multiple regulatory interactions.J Mol Biol. 1997;274:757-75.
40. Xu W,Doshi A,Lei M,Eck MJ,Harrison SC.Crystal structures of c-Src reveal features of its autoinhibitory mechanism.Mol Cell. 1999;3:629-38.
41. Hantschel O,Nagar B,Guettler S, et al.A myristoyl/phosphotyrosine switch regulates c-Abl.Cell. 2003;112:845-57.
42. Nagar B,Hantschel O,Young MA, et al.Structural basis for the autoinhibition of c-Abl tyrosine kinase.Cell. 2003;112:859-71.
43. Thomas SM,Brugge JS.Cellular functions regulated by Src family kinases.Annu Rev Cell Dev Biol. 1997;13:513-609.
44. Nagar B,Hantschel O,Seeliger M, et al.Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase.Mol Cell. 2006;21:787-98.
45. Filippakopoulos P,Kofler M,Hantschel O, et al.Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation.Cell. 2008;134:793-803.
46. Adrian FJ,Ding Q,Sim T, et al.Allosteric inhibitors of Bcr-abl-dependent cell proliferation.Nat Chem Biol. 2006;2:95-102.
47. Choi Y,Seeliger MA,Panjarian SB, et al.N-myristoylated c-Abl tyrosine kinase localizes to the endoplasmic reticulum upon binding to an allosteric inhibitor.J Biol Chem. 2009;284:29005-14.
48. Zhang J,Adrian FJ,Jahnke W, et al.Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors.Nature. 2010;463:501-6.
49. Shi Y,Alin K,Goff SP.Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity.Genes Dev. 1995;9:2583-97.
50. Miyazaki K,Matsuda S,Ichigotani Y, et al.Isolation and characterization of a novel human gene (NESH) which encodes a putative signaling molecule similar to e3B1 protein.Biochim Biophys Acta. 2000;1493:237-41.
51. Dai Z,Pendergast AM.Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity.Genes Dev. 1995;9:2569-82.
52. Ziemnicka-Kotula D,Xu J,Gu H, et al.Identification of a candidate human spectrin Src homology 3 domain-binding protein suggests a general mechanism of association of tyrosine kinases with the spectrin-based membrane skeleton.J Biol Chem. 1998;273:13681-92.
53. Xiong X,Cui P,Hossain S, et al.Allosteric inhibition of the nonmyristoylated c-Abl tyrosine kinase by phosphopeptides derived from Abi1/Hssh3bp1.Biochim Biophys Acta. 2008;1783:737-47.
54. Dubielecka PM,Machida K,Xiong X, et al.Abi1/Hssh3bp1 pY213 links Abl kinase signaling to p85 regulatory subunit of PI-3 kinase in regulation of macropinocytosis in LNCaP cells.FEBS Lett. 2010;584:3279-86.
55. Jung JH,Pendergast AM,Zipfel PA,Traugh JA.Phosphorylation of c-Abl by protein kinase Pak2 regulates differential binding of ABI2 and CRK.Biochemistry. 2008;47:1094-104.
56. Cowburn D,Zheng J,Xu Q,Barany G.Enhanced affinities and specificities of consolidated ligands for the Src homology (SH) 3 and SH2 domains of Abelson protein-tyrosine kinase.J Biol Chem. 1995;270:26738-41.
57. Birge RB,Kalodimos C,Inagaki F,Tanaka S.Crk and CrkL adaptor proteins: networks for physiological and pathological signaling.Cell Commun Signal. 2009;7:13.
58. Kobashigawa Y,Sakai M,Naito M, et al.Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK.Nat Struct Mol Biol. 2007;14:503-10.
59. Jankowski W,Saleh T,Pai MT,Sriram G,Birge RB,Kalodimos CG.Domain organization differences explain Bcr-Abl's preference for CrkL over CrkII.Nat Chem Biol. 2012;8:590-6.
60. Antoku S,Mayer BJ.Distinct roles for Crk adaptor isoforms in actin reorganization induced by extracellular signals.J Cell Sci. 2009;122:4228-38.
61. Sriram G,Reichman C,Tunceroglu A, et al.Phosphorylation of Crk on tyrosine 251 in the RT loop of the SH3C domain promotes Abl kinase transactivation.Oncogene. 2011;30:4645-55.
62. Anafi M,Rosen MK,Gish GD,Kay LE,Pawson T.A potential SH3 domain-binding site in the Crk SH2 domain.J Biol Chem. 1996;271:21365-74.
63. Wojcik J,Hantschel O,Grebien F, et al.A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain.Nat Struct Mol Biol. 2010;17:519-27.
64. Grebien F,Hantschel O,Wojcik J, et al.Targeting the SH2-kinase interface in Bcr-Abl inhibits leukemogenesis.Cell. 2011;147:306-19.
65. Filippakopoulos P,Muller S,Knapp S.SH2 domains: modulators of nonreceptor tyrosine kinase activity.Curr Opin Struct Biol. 2009;19:643-9.
66. Sriram G,Birge RB.Emerging roles for crk in human cancer.Genes Cancer. 2010;1:1132-9.
67. Miller CT,Chen G,Gharib TG, et al.Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas.Oncogene. 2003;22:7950-7.
68. Kim YH,Kwei KA,Girard L, et al.Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer.Oncogene. 2010;29:1421-30.
69. Rodrigues SP,Fathers KE,Chan G, et al.CrkI and CrkII function as key signaling integrators for migration and invasion of cancer cells.Mol Cancer Res. 2005;3:183-94.
70. Fathers KE,Rodrigues S,Zuo D, et al.CrkII transgene induces atypical mammary gland development and tumorigenesis.Am J Pathol. 2010;176:446-60.
71. Feng R,Chen X,Yu Y, et al.miR-126 functions as a tumour suppressor in human gastric cancer.Cancer Lett. 2010;298:50-63.
72. Wang L,Tabu K,Kimura T, et al.Signaling adaptor protein Crk is indispensable for malignant feature of glioblastoma cell line KMG4.Biochem Biophys Res Commun. 2007;362:976-81.
73. Cui M,Yu W,Dong J,Chen J,Zhang X,Liu Y.Downregulation of ABI1 expression affects the progression and prognosis of human gastric carcinoma.Med Oncol. 2010;27:632-9.
74. Macoska JA,Xu J,Ziemnicka D,Schwab TS,Rubin MA,Kotula L.Loss of expression of human spectrin src homology domain binding protein 1 is associated with 10p loss in human prostatic adenocarcinoma.Neoplasia. 2001;3:99-104.
75. Xiong X,Chorzalska A,Dubielecka PM, et al.Disruption of Abi1/Hssh3bp1 expression induces prostatic epithelial neoplasia in conditional Abi1/Hssh3bp1 mice.Oncogenesis. 2012;1:e26.
76. Kotula L.Abi1, a critical molecule coordinating actin cytoskeleton reorganization with PI-3 kinase and growth signaling.FEBS Lett. 2012;586:2790-4.
77. Silva JM,Ezhkova E,Silva J, et al.Cyfip1 is a putative invasion suppressor in epithelial cancers.Cell. 2009;137:1047-61.
78. Yu W,Sun X,Clough N,Cobos E,Tao Y,Dai Z.Abi1 gene silencing by short hairpin RNA impairs Bcr-Abl-induced cell adhesion and migration in vitro and leukemogenesis in vivo.Carcinogenesis. 2008;29:1717-24.
79. Li Y,Clough N,Sun X, et al.Bcr-Abl induces abnormal cytoskeleton remodeling, beta1 integrin clustering and increased cell adhesion to fibronectin through the Abl interactor 1 pathway.J Cell Sci. 2007;120:1436-46.
80. Sun X,Li C,Zhuang C, et al.Abl interactor 1 regulates Src-Id1-matrix metalloproteinase 9 axis and is required for invadopodia formation, extracellular matrix degradation and tumor growth of human breast cancer cells.Carcinogenesis. 2009;30:2109-16.
81. Kurisu S,Takenawa T.WASP and WAVE family proteins: friends or foes in cancer invasion?.Cancer Sci. 2010;101:2093-104.
82. Gu JJ,Lavau CP,Pugacheva E,Soderblom EJ,Moseley MA,Pendergast AM.Abl family kinases modulate T cell-mediated inflammation and chemokine-induced migration through the adaptor HEF1 and the GTPase Rap1.Sci Signal. 2012;5:.
83. Gligorijevic B,Wyckoff J,Yamaguchi H,Wang Y,Roussos ET,Condeelis J.N-WASP-mediated invadopodium formation is involved in intravasation and lung metastasis of mammary tumors.J Cell Sci. 2012;125:724-34.
84. Takenawa T,Suetsugu S.The WASP-WAVE protein network: connecting the membrane to the cytoskeleton.Nat Rev. 2007;8:37-48.
85. Wang C,Tran-Thanh D,Moreno JC, et al.Expression of Abl interactor 1 and its prognostic significance in breast cancer: a tissue-array-based investigation.Breast Cancer Res Treat. 2011;129:373-86.
86. Wang C,Navab R,Iakovlev V, et al.Abelson interactor protein-1 positively regulates breast cancer cell proliferation, migration, and invasion.Mol Cancer Res. 2007;5:1031-9.
87. Jia S,Liu Z,Zhang S, et al.Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis.Nature. 2008;454:776-9.
88. Fernando HS,Sanders AJ,Kynaston HG,Jiang WG.WAVE1 is associated with invasiveness and growth of prostate cancer cells.J Urol. 2008;180:1515-21.
89. Sossey-Alaoui K,Safina A,Li X, et al.Down-regulation of WAVE3, a metastasis promoter gene, inhibits invasion and metastasis of breast cancer cells.Am J Pathol. 2007;170:2112-21.
90. Fernando HS,Sanders AJ,Kynaston HG,Jiang WG.WAVE3 is associated with invasiveness in prostate cancer cells.Urol Oncol. 2010;28:320-7.
91. Dubielecka PM,Ladwein KI,Xiong X, et al.Essential role for Abi1 in embryonic survival and WAVE2 complex integrity.Proc Natl Acad Sci U S A. 2011;108:7022-7.
92. Dubielecka PM,Cui P,Xiong X, et al.Differential regulation of macropinocytosis by Abi1/Hssh3bp1 isoforms.PloS One. 2010;5:e10430.
93. Sriram G,Birge RB.Commentary. The carboxyl-terminal Crk SH3 domain: regulatory strategies and new perspectives.FEBS Lett. 2012;586:2615-8.
94. Tanis KQ,Veach D,Duewel HS,Bornmann WG,Koleske AJ.Two distinct phosphorylation pathways have additive effects on Abl family kinase activation.Mol Cell Biol. 2003;23:3884-96.
95. Baba RA,Bhat HF,Wani LA, et al.E3B1/ABI-1 isoforms are down-regulated in cancers of human gastrointestinal tract.Dis Markers. 2012;32:273-9.
96. Steinestel K,Bruderlein S,Steinestel J, et al.Expression of Abelson interactor 1 (Abi1) correlates with inflammation, KRAS mutation and adenomatous change during colonic carcinogenesis.PloS One. 2012;7:e40671.
97. Taki T,Shibuya N,Taniwaki M, et al.ABI-1, a human homolog to mouse Abl-interactor 1, fuses the MLL gene in acute myeloid leukemia with t(10;11)(p11.2;q23).Blood. 1998;92:1125-30.
98. Shibuya N,Taki T,Mugishima H, et al.t(10;11)-acute leukemias with MLL-AF10 and MLL-ABI1 chimeric transcripts: specific expression patterns of ABI1 gene in leukemia and solid tumor cell lines.Genes Chromosomes Cancer. 2001;32:1-10.
99. Chen H,Wu X,Pan ZK,Huang S.Integrity of SOS1/EPS8/ABI1 tri-complex determines ovarian cancer metastasis.Cancer Res. 2010;70:9979-90.
100. Kang R,Tang D,Yu Y, et al.WAVE1 regulates Bcl-2 localization and phosphorylation in leukemia cells.Leukemia. 2010;24:177-86.
101. Fernando HS,Davies SR,Chhabra A, et al.Expression of the WASP verprolin-homologues (WAVE members) in human breast cancer.Oncology. 2007;73:376-83.
102. Semba S,Iwaya K,Matsubayashi J, et al.Coexpression of actin-related protein 2 and Wiskott-Aldrich syndrome family verproline-homologous protein 2 in adenocarcinoma of the lung.Clin Cancer Res. 2006;12:2449-54.
103. Iwaya K,Oikawa K,Semba S, et al.Correlation between liver metastasis of the colocalization of actin-related protein 2 and 3 complex and WAVE2 in colorectal carcinoma.Cancer Sci. 2007;98:992-9.
104. Kurisu S,Suetsugu S,Yamazaki D,Yamaguchi H,Takenawa T.Rac-WAVE2 signaling is involved in the invasive and metastatic phenotypes of murine melanoma cells.Oncogene. 2005;24:1309-19.
105. Sossey-Alaoui K,Su G,Malaj E,Roe B,Cowell JK.WAVE3, an actin-polymerization gene, is truncated and inactivated as a result of a constitutional t(1;13)(q21;q12) chromosome translocation in a patient with ganglioneuroblastoma.Oncogene. 2002;21:5967-74.
106. Yanagawa R,Furukawa Y,Tsunoda T, et al.Genome-wide screening of genes showing altered expression in liver metastases of human colorectal cancers by cDNA microarray.Neoplasia. 2001;3:395-401.
107. Chattopadhyay I,Phukan R,Singh A, et al.Molecular profiling to identify molecular mechanism in esophageal cancer with familial clustering.Oncol Rep. 2009;21:1135-46.
108. Martin TA,Pereira G,Watkins G,Mansel RE,Jiang WG.N-WASP is a putative tumour suppressor in breast cancer cells, in vitro and in vivo, and is associated with clinical outcome in patients with breast cancer.Clin Exp Metastasis. 2008;25:97-108.